Filter Results:
(354)
Show Results For
- All HBS Web
(354)
- People (2)
- News (140)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (71)
Show Results For
- All HBS Web
(354)
- People (2)
- News (140)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (71)
- 01 Jun 2000
- News
Managing the Map
Whitehead's genome research center. Renowned as a thoughtful, charismatic speaker on biotech issues, Lander memorably described the Human Genome Project as biology's version of the discovery and consolidation of the periodic table: "Not... View Details
Keywords: Peter K. Jacobs
- 19 Sep 2012
- Research & Ideas
Book Excerpt: “The Architecture of Innovation”
but the fund achieved impressive successes. For instance, it invested in biotech firms like Amgen, Cephalon, and Sepracor, and coinvested with major venture firms such as Kleiner Perkins and New Enterprise Associates. Its compensation... View Details
- Profile
Terrance McGuire
measured in multiple years rather than months. A high tech startup can see a marketplace, introduce a product and know pretty accurately whether its customers are going to purchase and use a product or service. A biotech venture might... View Details
- 03 Oct 2019
- News
Clubs Convene to Focus on Health Care
as a retiree, investors, and entrepreneurs; alumni working in a range of health care sectors, from biotech and research to pharma and the provider side of it as well. It was a chance to get connected. There was no agenda and no speaker.... View Details
- 01 Mar 2007
- News
Daniel Vasella
characterized by three things. First, we work closely with academic institutions and with biotech companies. Secondly, we created a genomics institute at The Scripps Research Institute in La Jolla, California. And the most important step... View Details
- Web
A Eureka Moment | Social Enterprise | Harvard Business School
further.” Bucala also launched a new venture focused on healthcare, serving as CEO at MIFCOR [www.mifcortx.com], a biotech company pursuing therapies for damaged heart tissue that recently received early stage funding. “I’m the sort of... View Details
- 30 Sep 2019
- Blog Post
The Health Care Initiative at HBS
research with over 100 cases, books, and articles about the topic. The school also offers several joint programs related to health care including an MD-MBA, DMD-MBA, MPP-MBA and two MS-MBAs, one with a focus on biotech and life sciences... View Details
- 01 Dec 2003
- News
The Next Big Thing
approach to meeting them. This could produce as many as 100,000 high-paying jobs in biotech companies alone, Porter said. Harvard’s Bishop William Lawrence University Professor and an internationally recognized expert on strategy and... View Details
- 06 May 2008
- First Look
First Look: May 6, 2008
Fibrosis Foundation: Venture Philanthropy Funding for Biotech Harvard Business School Case 808-005 In 2001, Vertex Pharmaceuticals Incorporated acquired the San Diego-based biotech company, Aurora... View Details
Keywords: Martha Lagace
- 27 Apr 2023
- News
Life Preserver
transplant organs from a few hours to a few days or possibly longer. "Eventually, we want to stop biological time," says Giwa, who is CEO of Sylvatica. (He left Ossium in 2018 but also is the cofounder and chairman of Elevian, a biotech... View Details
Keywords: April White
- 01 Jun 2018
- News
Floor It
case study with the Multiple Myeloma Research Foundation, GNS Healthcare, the Moffitt Cancer Center’s ORIEN program, and biotech firm Foundation Medicine. Rethinking Drug Trials In an adaptive platform trial, different drugs are... View Details
Keywords: Julia Hanna; illustration by Mengxin Li
- 01 Dec 2013
- News
Your Own Medicine
searching for new leads. In 2008, Benjy came across an article on halofuginone (HT-100), a drug compound derived from an ancient Chinese herb that had shown promising results in treating muscular dystrophy in mice. They tracked it down to an Israeli View Details
- Web
Class Profile | MBA
/ E-Commerce 9% Financial Services 10% Health Care / Biotech 8% Manufacturing / Industrial / Energy 9% Media / Entertainment / Travel 4% Military 5% Nonprofit / Government / Education 6% Services 2% Technology 12% Venture Capital /... View Details
- 15 Dec 2020
- Blog Post
MBA Voices Blog: A Year in Review
decision maker. Read More 4 Things to Know About the MS/MBA Biotech “I was initially attracted to Harvard’s MS/MBA Biotechnology: Life Sciences program because of the emphasis on ethical decision making, and ultimately chose the program... View Details
- 01 Jun 2009
- Lessons from the Classroom
The Challenges of Investing in Science-Based Innovation
science-based research is something the heads of top biotech and pharmas learned long ago: There are few instant payoffs to please investors. Just ask Raymond Gilmartin, former chairman, president, and CEO of Merck & Co., who now... View Details
- 17 Dec 2001
- Research & Ideas
Enterprising Women
by the firm's mission and saw that it had been self-sufficient for nearly seven years, Fisher's task became much easier: In three stages, over the course of 2000, she raised venture capital funds of $11 million, $48 million, and $75 million. That same year, she founded... View Details
Keywords: by Julia Hanna
- 01 Mar 2019
- News
The Blue-Green Revolution
biotech company cofounded by genomics pioneer Craig Venter and Nobel Laureate Hamilton Smith, together with writer and life sciences investor Juan Enriquez (MBA 1986). And it may soon come to fruition: Last March, in the wake of a... View Details
- 04 Sep 2019
- News
Advancing Diagnostics that Can Save Lives
MS/MBA Biotechnology: Life Sciences Program will build upon students’ existing biotech and life sciences knowledge and equip them with the latest business and scientific insights. The first cohort will start in August 2020. The joint... View Details
Keywords: Susan Young
- Web
Middle East & North Africa - Global Activities 2021
Graduate School of Arts and Sciences, and Harvard Medical School through the Harvard Department of Stem Cell and Regenerative Biology—to explore biotech careers in emerging markets, particularly in the Middle East and North Africa region.... View Details
- 12 Oct 2006
- First Look
First Look: October 12, 2006
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707438 PublicationsScience Business: Promise, Performance and the Future of Biotech Author:Gary P. Pisano Publication:Harvard Business School Press (forthcoming) Abstract... View Details
Keywords: Sean Silverthorne